Accomplished global executive led and developed a range of diverse and complex pharma sector businesses with proven sales, marketing, market access, commercial operations, strategic planning, portfolio strategy and business development track record of success on both inline and pipeline assets for large, complex organizations globally.
Courageous and decisive P&L business leader with proven track record of achieving aspirational organizational objectives having profitably turned around an under-performing businesses exceeding goals consistently.
Influential business leader having led and contributed to executive committees, strategic initiatives and global programs shaping and driving strategy for multinational organizations.
Insightful strategist and change agent having overcome resistance and gained buy-in to successfully execute key strategic initiatives.
Passionate customer advocate skilled at balancing both internal and external priorities having eliminated barriers to access in various markets around the globe.
Strategic partner skilled at influencing and collaborating with global, region and local networks across a complex, matrix structure capable of establishing sponsorship and consensus under highly resistant and challenging conditions.
Authentic leader with a proven track record of building, investing in and empowering teams.
Created and Executed the market access framework establishing Novartis Vaccines presence in various markets across Europe
Led cross functional teams of finance, legal, supply chain, manufacturing and packaging to support Novartis Vaccines geographic expansion initiatives
Owned financials outlook planning including P&L, Cash Flows, EBIT and NPV
Led processes' improvement initiatives starting with strategic processes of business planning, forecasting and launch planning also extended to operational aspects of incoterms, payment terms, Forex management, multi-language packaging and label implications in various markets
Has been working with KoLs in oncology, rheumatology, anemia and vaccines for the past 10 years
Successfully built Roche and Novartis advisory boards in those disease areas and aligned them for productive outcomes including better market understanding, high impact strategic approaches, influential lobbying for driving pricing and reimbursement
Managed KoL profiling, segmentation and resources allocation
Identified and developed new KoLs through perceptorship programs, speakers' trainings and media trainings